Currently out of the existing stock ratings of Julian Harrison, 42 are a BUY (82.35%), 9 are a HOLD (17.65%).

Julian Harrison

Work Performance Price Targets & Ratings Chart

Analyst Julian Harrison, currently employed at BTIG, carries an average stock price target met ratio of 49.33% that have a potential upside of 54.91% achieved within 270 days.

Julian Harrison’s has documented 92 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KROS, Keros Therapeutics  at 12-Dec-2024.

Wall Street Analyst Julian Harrison

Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.

Average potential price target upside

PTGX Protagonist Therapeutics LQDA Liquidia Technologies AVTE Aerovate Therapeutics RXDX Prometheus Biosciences KROS Keros Therapeutics  ACRS Aclaris Therapeutics AXLA Axcella Health VKTX Viking Therapeutics MORF Morphic CBAY Cymabay Therapeu MLTX MoonLake Immunotherapeutics ANAB AnaptysBio OTLK OUTLOOK THERAPEUTICS INC RZLT Rezolute VRDN Viridian Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$32.53 (68.53%)

$80

13 days ago
(19-May-2025)

27/31 (87.1%)

$34.43 (75.55%)

284

Buy

$61

$13.53 (28.50%)

$58

2 months 22 days ago
(10-Mar-2025)

10/11 (90.91%)

$5.05 (9.03%)

170

Buy

$57

$9.53 (20.08%)

$53

2 months 28 days ago
(04-Mar-2025)

5/5 (100%)

$18.34 (47.44%)

106

Hold

$67

$19.53 (41.14%)

$51

6 months 10 days ago
(22-Nov-2024)

4/5 (80%)

$20.54 (44.21%)

653

Buy

$35

$-12.47 (-26.27%)

$35

1 years 10 months 29 days ago
(03-Jul-2023)

6/10 (60%)

$12.69 (56.88%)

1001

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Julian Harrison is most bullish on?

Potential upside of $0 has been obtained for KROS (KEROS THERAPEUTICS )

What Year was the first public recommendation made by Julian Harrison?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?